Longevity maximalist currently building rejuvenating gene therapies based on in vivo partial cellular reprogramming with Yamanaka factors.
PhD, Doctor of Sciences, researcher in the area of molecular dynamics and drug discovery. CSO of Receptor.AI. https://t.me/semen_yesylevskyy
Text to speech